{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T22:15:52Z","timestamp":1789683352731,"version":"4.0.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":731,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["MOSHIR19K01"],"award-info":[{"award-number":["MOSHIR19K01"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.jcf.2022.10.006","type":"journal-article","created":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T21:15:11Z","timestamp":1667078111000},"page":"266-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4986-7134","authenticated-orcid":false,"given":"Baha","family":"Moshiree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3399-3390","authenticated-orcid":false,"given":"A. Jay","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0777-0329","authenticated-orcid":false,"given":"Phuong T.","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8506-8597","authenticated-orcid":false,"given":"Umer","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ufret-Vincenty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonya L.","family":"Heltshe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher H.","family":"Goss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Jane","family":"Schwarzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3685-4078","authenticated-orcid":false,"given":"Drucy","family":"Borowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7088-8530","authenticated-orcid":false,"given":"Meghana","family":"Sathe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2022.10.006_bib0001","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1126\/science.2475911","article-title":"Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA","volume":"245","author":"Riordan","year":"1989","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.jcf.2022.10.006_bib0002","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.jcf.2012.05.001","article-title":"Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis","volume":"11","author":"Ooi","year":"2012","journal-title":"J Cyst Fibros"},{"issue":"19","key":"10.1016\/j.jcf.2022.10.006_bib0003","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"VX17-445-102 study group. elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N Engl J Med"},{"issue":"10212","key":"10.1016\/j.jcf.2022.10.006_bib0004","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"VX17-445-103 Trial Group. Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jcf.2022.10.006_bib0005","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1055\/s-0039-1697591","article-title":"Gastrointestinal and hepatobiliary disease in cystic fibrosis","volume":"40","author":"Gabel","year":"2019","journal-title":"Semin Respir Crit Care Med."},{"issue":"7","key":"10.1016\/j.jcf.2022.10.006_bib0006","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1177\/2050640619841545","article-title":"A high prevalence of chronic gastrointestinal symptoms in adults with cystic fibrosis is detected using tools already validated in other GI Disorders","volume":"7","author":"Bu'Hussain","year":"2019","journal-title":"UEG J"},{"issue":"11","key":"10.1016\/j.jcf.2022.10.006_bib0007","article-title":"Pancreatic enzyme replacement therapy for people with cystic fibrosis","volume":"11","author":"Somaraju","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jcf.2022.10.006_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174463","article-title":"Abdominal symptoms in cystic fibrosis and their relation to genotype, history, clinical and laboratory findings","volume":"12","author":"Tabori","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.jcf.2022.10.006_bib0009","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jcf.2018.11.010","article-title":"Beyond the expected: identifying broad research priorities of researchers and the cystic fibrosis community","volume":"18","author":"Hollin","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2022.10.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2020.12.021","article-title":"Designing the GALAXY study: partnering with the cystic fibrosis community to optimize assessment of gastrointestinal symptoms","author":"Freeman","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2022.10.006_bib0011","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcf.2021.07.002","article-title":"Utilization of electronic patient-reported outcome measures in cystic fibrosis research: application to the GALAXY study","volume":"20","author":"Sathe","year":"2021","journal-title":"J Cyst Fibros"},{"issue":"4","key":"10.1016\/j.jcf.2022.10.006_bib0012","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s40271-019-00361-2","article-title":"Validity and reliability of a novel multimodal questionnaire for the assessment of abdominal symptoms in people with cystic fibrosis (CFAbd-Score)","volume":"12","author":"Jaudszus","year":"2019","journal-title":"Patient"},{"issue":"12","key":"10.1016\/j.jcf.2022.10.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225004","article-title":"MyCyFAPP consortium. Assessing gastro-intestinal related quality of life in cystic fibrosis: validation of PedsQL GI in children and their parents","volume":"14","author":"Boon","year":"2019","journal-title":"PLoS ONE"},{"issue":"10","key":"10.1016\/j.jcf.2022.10.006_bib0014","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s11136-004-9567-x","article-title":"Development, and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders","volume":"13","author":"Rentz","year":"2004","journal-title":"Qual Life Res"},{"issue":"11\u201312","key":"10.1016\/j.jcf.2022.10.006_bib0015","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/apt.14349","article-title":"The PAC-SYM questionnaire for chronic constipation: defining the minimal important difference","volume":"46","author":"Yiannakou","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcf.2022.10.006_bib0016","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1080\/003655299750025327","article-title":"Psychometric validation of a constipation symptom assessment questionnaire","volume":"34","author":"Frank","year":"1999","journal-title":"Scand J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jcf.2022.10.006_bib0017","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/00365520510012208","article-title":"Development, and validation of the patient assessment of constipation quality of life questionnaire","volume":"40","author":"Marquis","year":"2005","journal-title":"Scand J Gastroenterol"},{"issue":"7","key":"10.1016\/j.jcf.2022.10.006_bib0018","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1111\/apt.13746","article-title":"Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhea-predominant irritable bowel syndrome","volume":"44","author":"Blake","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jcf.2022.10.006_bib0019","unstructured":"R. Core Team (2020) R: a language and environment for statistical computing. r foundation for statistical computing, Vienna, Austria. https:\/\/www.r-project.org\/"},{"key":"10.1016\/j.jcf.2022.10.006_bib0020","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.cgh.2020.03.056","article-title":"Management of chronic abdominal distension and bloating","volume":"19","author":"Lacy","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jcf.2022.10.006_bib0021","doi-asserted-by":"crossref","first-page":"17","DOI":"10.14309\/ajg.0000000000001036","article-title":"ACG clinical guideline: management of irritable bowel syndrome","volume":"116","author":"BE","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jcf.2022.10.006_bib0022","first-page":"631","article-title":"Small intestinal overgrowth is frequent in cystic fibrosis: combined hydrogen and methane measurements are required for its detection","volume":"56","author":"Lisowska","year":"2009","journal-title":"Acta Biochim Pol"},{"key":"10.1016\/j.jcf.2022.10.006_bib0023","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00535-018-1509-4","article-title":"The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin","volume":"54","author":"Furnari","year":"2019","journal-title":"J Gastroenterol"},{"issue":"suppl 24","key":"10.1016\/j.jcf.2022.10.006_bib0024","first-page":"a398","article-title":"Cystic fibrosis, and incontinence in children","volume":"110","author":"Moraes","year":"2002","journal-title":"Pediatr Pulmonol"},{"issue":"9","key":"10.1016\/j.jcf.2022.10.006_bib0025","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1345\/aph.1Q219","article-title":"Lubiprostone for constipation in adults with cystic fibrosis: a pilot study","volume":"45","author":"O'Brien","year":"2011","journal-title":"Ann Pharmacother"},{"issue":"5","key":"10.1016\/j.jcf.2022.10.006_bib0026","doi-asserted-by":"crossref","first-page":"288","DOI":"10.14740\/gr917w","article-title":"Proton pump inhibitor use is associated with an increased frequency of hospitalization in patients with cystic fibrosis","volume":"10","author":"Ayoub","year":"2017","journal-title":"Gastroenterol Res"},{"key":"10.1016\/j.jcf.2022.10.006_bib0027","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2466-14-21","article-title":"Effect of esomeprazole versus placebo on pulmonary exacerbations in cystic fibrosis","volume":"14","author":"Dimango","year":"2014","journal-title":"BMC Pulm Med"},{"issue":"2","key":"10.1016\/j.jcf.2022.10.006_bib0028","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MPG.0b013e3181acae98","article-title":"Characteristics of gastroesophageal reflux and potential risk of gastric content aspiration in children with cystic fibrosis","volume":"50","author":"Blondeau","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"4","key":"10.1016\/j.jcf.2022.10.006_bib0029","first-page":"1071","article-title":"Sex- and Gender-related differences in common functional gastroenterologic disorders","volume":"96","author":"Narayanan","year":"2021","journal-title":"Thematic Rev Womens Health"},{"issue":"9","key":"10.1016\/j.jcf.2022.10.006_bib0030","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1111\/apt.13378","article-title":"Systemic review: instruments to assess abdominal pain in irritable bowel syndrome","volume":"42","author":"Mujagic Z Keszthelyi","year":"2015","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.jcf.2022.10.006_bib0031","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jcf.2021.02.003","volume":"20","author":"Nichols","year":"2021","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322013881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199322013881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T21:48:16Z","timestamp":1761601696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199322013881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S1569199322013881"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2022.10.006","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multicenter prospective study showing a high gastrointestinal symptom burden in cystic fibrosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2022.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 European Cystic Fibrosis Society. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}